Welcome to our dedicated page for Fmc news (Ticker: FMC), a resource for investors and traders seeking the latest updates and insights on Fmc stock.
FMC Corporation reports news on its global agricultural sciences business, including crop protection solutions, biologicals, crop nutrition, digital and precision agriculture, and research into herbicide, insecticide and fungicide active ingredients. Company updates commonly cover quarterly results, outlook commentary, dividend declarations, executive conference appearances, and regulatory approvals for products such as Isoflex® active.
FMC news also reflects the operating issues of a crop protection supplier, including regional revenue trends, product commercialization, operational priorities, capital-structure matters, and governance developments affecting its board and incentive plans.
FMC (NYSE: FMC) announced the election of Michael F. Barry to its Board of Directors, effective February 27, 2026. He will join the Audit and Compensation and Human Capital committees and brings 30+ years in specialty chemicals and prior CEO and chairman experience.
Barry led Quaker Houghton through major growth, including revenue expansion from $451 million in 2009 to $1.8 billion in 2021 and 27 strategic acquisitions, and will advise on FMC's 2026 strategic priorities.
FMC (NYSE: FMC) announced that HRAC has classified rimisoxafen as the industry's first dual mode of action herbicide, designated under HRAC Groups 12 and 32. The classification recognizes dual inhibition of PDS and SDPS, increasing the barrier to weed resistance.
Rimisoxafen targets palmer amaranth and waterhemp, is intended for broadacre crops, was discovered at FMC's Stine Research Center, and regulatory dossiers will begin in 2026.
FMC (NYSE: FMC) said CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the Bank of America Global Agriculture and Materials Conference on February 25, 2026 at 2:45 p.m. ET. A live webcast will be available at www.fmc.com/investors.
FMC (NYSE:FMC) announced the Board has authorized exploration of strategic options, including a potential sale, while outlining 2026 priorities to strengthen the balance sheet and commercialize new active ingredients.
2026 guidance: $3.60–$3.80B revenue, $670–$730M Adjusted EBITDA, $1.63–$1.89 Adjusted EPS; company plans to pay down $1B debt via asset sales/licensing.
FMC (NYSE: FMC) announced its 2026 Annual Meeting of Stockholders will be held via live webcast on Tuesday, April 28, 2026 at 2:00 p.m. ET. The board set the record date as close of business Friday, February 27, 2026 to determine stockholders entitled to notice and voting rights. Additional details will be provided in the proxy statement and proxy materials. Instructions to access the webcast will be available on the company's Investor Relations website at https://investors.fmc.com.
FMC (NYSE: FMC) will release fourth quarter 2025 earnings on Wednesday, February 4, 2026 after market close via PR Newswire and the company's investor website.
The company will host a public webcast conference call on Thursday, February 5, 2026 at 9:00 a.m. ET. Webcast and telephone access details, including U.S. local and toll-free numbers, global dial‑ins, an access code, and a pre‑registration link, are available on the investor site.
A replay will be available online and by telephone from 11:00 a.m. ET on February 5, 2026 until February 12, 2026.
FMC (NYSE: FMC) announced a regular quarterly cash dividend of $0.08 per share. The dividend is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This is a routine cash distribution to eligible shareholders.
FMC (NYSE: FMC) announced that Chairman and CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the Goldman Sachs Industrials and Materials Conference on December 3, 2025 at 1:30 p.m. Eastern Time.
A live webcast of the presentation will be available at www.fmc.com/investors.
FMC (NYSE: FMC) announced that Ronaldo Pereira, president, will step down effective December 15, 2025 after 28 years with the company. The decision was reached by mutual agreement with chairman and CEO Pierre Brondeau. Pereira will remain in an advisory capacity until December 15, 2025 to support a smooth transition. Management praised Pereira's leadership, citing transformation of grower relationships in Latin America and business growth in North America.
The company emphasized continuity through the agreed transition timeline and internal coordination.
FMC (NYSE:FMC) reported Q3 2025 revenue of $542M, down 49% year-over-year, driven by one-time commercial actions in India as the business is held for sale. Excluding India, revenue was $961M, down 10% versus prior year and 11% organically. GAAP net loss was $569M (loss per diluted share $4.52) after ~$510M of India-related charges and write-downs. Adjusted EBITDA was $236M (+17% YoY) and adjusted EPS was $0.89 (+30% YoY). Full-year guidance was lowered: revenue to $3.92B–$4.02B, Adjusted EBITDA to $830M–$870M, adjusted EPS to $2.92–$3.14, and free cash flow to negative $200M–$0. Quarterly dividend reduced to $0.08 to prioritize debt reduction.